- Published at
- by manilatimes.net
mixed
mixed
News for Five Prime Therapeutics, Inc. (FPRX)
- Published at
- by investing.com
mixedmixed89bio names Francis Sarena as new COO By Investing.com
89bio names Francis Sarena as new COO- Published at
- by globenewswire.com
mixedmixed89bio Appoints Francis Sarena as Chief Operating Officer
SAN FRANCISCO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...- Published at
- by marketscreener.com
mixedmixedTScan Therapeutics Announces Updates to its Board of Directors
Garry A. Nicholson, an experienced executive with regulatory and commercial expertise, joins the Board of Directors Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role...- Published at
- by globenewswire.com
neutralneutral- Published at
- by prnewswire.com
mixedmixedAMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data...- Published at
- by sec.gov
positivepositiveDaniel V.T. Catenacci
Litigation Release No. 25813 / August 21, 2023 Securities and Exchange Commission v. Daniel V.T. Catenacci, No. 1:21-cv-06718 (N.D. Ill. filed Dec. 17, 2021) ...- Published at
- by globenewswire.com
mixedmixedHarpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society (IMS) Annual Meeting and the European Society for Medical...- Published at
- by prnewswire.com
mixedmixed- Published at
- by marketscreener.com
positivepositiveHarpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2023 -- Harpoon Therapeutics, Inc. , a clinical-stage immuno-oncology company developing novel T cell engagers, today announced the appointment of Haibo Wang...- Published at
- by marketscreener.com
mixedmixedYumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K
January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA Disclaimers and other information Cautionary... | January 5, 2023- Published at
- by gurufocus.com
mixedmixedHighland Capital Management Fu
GuruFocus Article or News written by insider and the topic is about:- Published at
- by markets.businessinsider.com
mixedmixedThe Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, the week ...- Published at
- by markets.businessinsider.com
mixedmixedBenzinga's Top Ratings Upgrades, Downgrades For March 5, 2021
Upgrades For Boeing Co (NYSE:BA), Canaccord Genuity upgraded the previous rating of Hold to Buy. In the fourth quarter, Boeing showed an ...NXTCCSCO.MXCSCO.BACSCOCIS.MUCIS.FCIS.DECIS.BEASAN2US.MU2US.F2US.BEXONA.HAXONA.DUXOMD.BAXOMVMD.TOVMDVIJ.FTLFP.FTLFP.BETIGRSWS.MUSWS.FSWS.BESWBIRIGN.MXRIGPQ3.FPFSPAYC.MXPAYCNKLAMS.SNMS.MXMSMISTMCRBFPRXFPLPYDZSIDWD.SGDWD.MUDWD.FDWD.DEDWD.BEDRQDQU.SGDQU.FDARCYX.MUCYX.FCYX.BECGNTVCGNTCDLXBOE.LBCO.SGBCO.MUBCO.FBCO.DEBCO.BEBACL.SNBA.SNBA.MXBAAZULBN.MXAZUL4.SAAZULAQMSAQK.MUAQK.FAQK.BE8NI.HM8NI.HA8NI.DE8NI.BE8AZA.SG8AZA.F8AZA.BE43D.F43D.BE1S9.SG1S9.F1S9.BE1M5.F0PY.SG0PY.MU0PY.F0PY.BEORCL.BAORCL- Published at
- by benzinga.com
mixedmixedBenzinga's Top Ratings Upgrades, Downgrades For March 5, 2021
Upgrades For Boeing Co (NYSE:BA), Canaccord Genuity upgraded the previous rating of Hold to Buy. In the fourth quarter, Boeing showed an EPS of ...- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...RO.SWRHHBFOPNTOCULFLGT.MXFLGTDMTK.MXDMTKATRCACORA5I.F7F0.F7F0.BE0OT.F0OT.BEYMTXVYGR.MXVYGRVT6.SGVT6.FVRPXVLONVIVEVIRIV7B1.SGV7B1.FV7B1.BETLISTARASNSESGTXSANAQUREQLGNONYN.FONYN.BEONCYONCWFONCRONC.TOOLMANRBONLSPNEXINBTXMRNA.MXMRNALTIA.FLHDXLEGNKRMDKPTIIMRAIKTICPT.MXICPTI4P.MUI4P.FI4P.BEGLTOGIS.MUGIS.FGIS.DEGIS.BEGILD.MXGILD.MIGILDGHDN.SGGHDN.MUGHDN.FGHDN.BEEPZMEPE.FEPE.BEDYNDBTXBVSBCTXFBCTXBCT.VBCLIATNXASMBAPTOAPS.TOALBPS.PAAFIBADCT8IY.MU8IY.F8IY.BE8BTA.F7R9B.MU7R9B.F7R9B.BE6XB.F2MT.F25K.SG25K.MU25K.F25K.BE1KPA.MU1KPA.F1KPA.BE0QF.SG0QF.MU0QF.F0QF.BETAKFPRXAPLSAMGN.BAAMGNAMG.MUAMG.FAMG.DEAMG.BEABCL8QQ.HM8QQ.F8QQ.BE1JK.MU1JK.F1JK.BE- Published at
- by marketscreener.com
mixedmixedALERT: Halper Sadeh LLP Investigates SVBI, FPRX, MIK, JCS; Shareholders are Encouraged to Contact the Firm
NEW YORK, March 4, 2021 /PRNewswire/ --?Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: ... | March 4, 2021- Published at
- by marketscreener.com
mixedmixedFIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm
NEW YORK, March 04, 2021 -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Five Prime...- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 237 companies set new 52-week highs. Interesting Highlights: Exxon Mobil (NYSE:XOM) was the largest firm by ...XOMWERNWBKWASHVRAVICIUSNAURBNUNTYUNFIUNFUMBFUFPTTSNTSBKTRMKTOWNTMSTTMPTHFFTCPCTCBKTBBKSYBTSSPSRCESMBKSMBCSMSLGGSIXSFSTSELFSBSISBLKSAFMSABRS4Y.DURRGBRRBIRNSTRMNIWRMNIRESRBBQEPPWFLPTRSPPBIPKXPFBCOVVOSBCONBON1.FOMCOLWN.FOISOBNKNXSTNFGNBTBMXMTDRMS.SNMS.MXMSMFCMATWLSTRLKFNLBCLBAILAMRKTBKRNYHWMHONEHMSTHFWAHBTGWRSGWBGTSGNKWFGNKGLBZFRBKFPRXFORRFNLCFMNBFLMNFIXFISIFFWMFBPFBKFBCFANGESTEEMREBMTEBFEBCDWD.SGDWD.MUDWD.FDWD.DEDWD.BEDELLCVXCVGWCTBICTBCNTYCNDTCMRECMICLRCLBKCGBDCFXCFFNCFBKCBZCBUCBNKCACCBXSBWBBUSEBURLBTO.FBTO.BEBSVNBRTBRKLBRCBOKFBHBBCBPBBSIBBDCBANFAVDATRCARCCANFAEOADS5SZ.F1IU.FXECWSBFWSBCSFBSSFBCSANMMODJYNTIPIBOCGABCGAB.FFUNESGRDOXDORMCVBFCFBAUBAMVECUMHTPLSVBINNIMSBIMCYHCKTFSVFRMEFM5.FESSAENVABMTCATHABTX241A.MU- Published at
- by marketwatch.com
positivepositiveAmgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio
Amgen Inc. undefined announced Thursday an agreement to buy biotechnology company Five Prime Therapeutics Inc. undefined in a cash deal valued at $1.9...